Hypothalamic control of bone formation: Distinct actions of leptin and Y2 receptor pathways

作者: Paul A Baldock , Amanda Sainsbury , Susan Allison , En-Ju D Lin , Michelle Couzens

DOI: 10.1359/JBMR.050523

关键词:

摘要: Leptin and Y2 receptors on hypothalamic NPY neurons mediate leptin effects energy homeostasis; however, their interaction in modulating osteoblast activity is not established. Here, direct testing of this possibility indicates distinct mechanisms action for anti-osteogenic Y2(-/-) anabolic pathways bone formation. Introduction: Central enhancement formation by observed leptin-deficient oblob receptor null mice. Similar elevation central neuropeptide Y (NPY) expression these two models suggest a shared pathway between the control physiology. The aim study was to test whether regulate same or mechanisms. Materials Methods: concomitant deficiency controlling examined double mutant mice, determine have additive effects. Interaction excess deletion using recombinant adeno-associated viral vector overproduction (AAV-NPY) produce weight gain thus adult Cancellous volume cell function were assessed. Results: Osteoblast comparably elevated oblob, Y2(-/-), However, greater resorption mice reduced cancellous compared with Y2(-/-). Both wildtype AAV-NPY exhibited marked white adipose tissue accumulation hence expression, thereby reducing activity. Despite effect obese model, remained significantly than Conclusions: This suggests that key regulator leptin-dependent activity, because both stimulation inhibition can occur presence high NPY. acts consistently stimulate formation; contrast, continues suppress as circulating levels increase. As result, they act increasingly opposition obesity becomes more marked. Thus, absence leptin, response loss be distinguished. increase physiological levels, signaling are revealed.

参考文章(21)
Patricia Ducy, Michael Amling, Shu Takeda, Matthias Priemel, Arndt F Schilling, Frank T Beil, Jianhe Shen, Charles Vinson, Johannes M Rueger, Gerard Karsenty, Leptin Inhibits Bone Formation through a Hypothalamic Relay: A Central Control of Bone Mass Cell. ,vol. 100, pp. 197- 207 ,(2000) , 10.1016/S0092-8674(00)81558-5
Philippe Naveilhan, Lennart Svensson, Susanne Nyström, A.Jonas Ekstrand, Patrik Ernfors, Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Peptides. ,vol. 23, pp. 1087- 1091 ,(2002) , 10.1016/S0196-9781(02)00042-6
Peter J King, Gareth Williams, Henri Doods, Peter S Widdowson, Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release European Journal of Pharmacology. ,vol. 396, ,(2000) , 10.1016/S0014-2999(00)00230-2
B.Glenn Stanley, Sarah F. Leibowitz, Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sciences. ,vol. 35, pp. 2635- 2642 ,(1984) , 10.1016/0024-3205(84)90032-8
Jay C. Erickson, Kathy E. Clegg, Richard D. Palmiter, Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y Nature. ,vol. 381, pp. 415- 418 ,(1996) , 10.1038/381415A0
Florent Elefteriou, Shu Takeda, Xiuyun Liu, Dawna Armstrong, Gerard Karsenty, Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass Endocrinology. ,vol. 144, pp. 3842- 3847 ,(2003) , 10.1210/EN.2003-0369
J. Halaas, K. Gajiwala, M Maffei, S. Cohen, B. Chait, D Rabinowitz, R. Lallone, S. Burley, J. Friedman, Weight-reducing effects of the plasma protein encoded by the obese gene. Science. ,vol. 269, pp. 543- 546 ,(1995) , 10.1126/SCIENCE.7624777
B. Glenn Stanley, Stavroula E. Kyrkouli, Sharon Lampert, Sarah F. Leibowitz, Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity Peptides. ,vol. 7, pp. 1189- 1192 ,(1986) , 10.1016/0196-9781(86)90149-X
A. Sainsbury, C. Schwarzer, M. Couzens, S. Fetissov, S. Furtinger, A. Jenkins, H. M. Cox, G. Sperk, T. Hokfelt, H. Herzog, Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 8938- 8943 ,(2002) , 10.1073/PNAS.132043299
F. Elefteriou, S. Takeda, K. Ebihara, J. Magre, N. Patano, C. Ae Kim, Y. Ogawa, X. Liu, S. M. Ware, W. J. Craigen, J. J. Robert, C. Vinson, K. Nakao, J. Capeau, G. Karsenty, Serum leptin level is a regulator of bone mass Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 3258- 3263 ,(2004) , 10.1073/PNAS.0308744101